JP2022525121A5 - - Google Patents
Info
- Publication number
- JP2022525121A5 JP2022525121A5 JP2021555034A JP2021555034A JP2022525121A5 JP 2022525121 A5 JP2022525121 A5 JP 2022525121A5 JP 2021555034 A JP2021555034 A JP 2021555034A JP 2021555034 A JP2021555034 A JP 2021555034A JP 2022525121 A5 JP2022525121 A5 JP 2022525121A5
- Authority
- JP
- Japan
- Prior art keywords
- formula
- pharmaceutically acceptable
- acceptable salt
- compound according
- independently selected
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1902490.0A GB201902490D0 (en) | 2019-02-25 | 2019-02-25 | Novel compounds and pharmaceutical compositions thereof for the treatment of diseases |
| GB1902490.0 | 2019-02-25 | ||
| PCT/EP2020/054122 WO2020173739A1 (en) | 2019-02-25 | 2020-02-17 | Pyrazolopyridine derivatives as inhibitors of pask |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022525121A JP2022525121A (ja) | 2022-05-11 |
| JP2022525121A5 true JP2022525121A5 (enExample) | 2023-02-20 |
Family
ID=65998935
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021555034A Pending JP2022525121A (ja) | 2019-02-25 | 2020-02-17 | Ｐａｓｋの阻害剤としてのピラゾロピリジン誘導体 |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20220144823A1 (enExample) |
| EP (1) | EP3931191B1 (enExample) |
| JP (1) | JP2022525121A (enExample) |
| KR (1) | KR20210134001A (enExample) |
| CN (1) | CN113474344A (enExample) |
| AR (1) | AR124749A1 (enExample) |
| AU (1) | AU2020229041A1 (enExample) |
| BR (1) | BR112021016642A2 (enExample) |
| CA (1) | CA3130154A1 (enExample) |
| CO (1) | CO2021010485A2 (enExample) |
| ES (1) | ES2963409T3 (enExample) |
| GB (1) | GB201902490D0 (enExample) |
| IL (1) | IL285751A (enExample) |
| MA (1) | MA55074A (enExample) |
| MX (1) | MX2021010093A (enExample) |
| PH (1) | PH12021552032A1 (enExample) |
| SG (1) | SG11202109157TA (enExample) |
| TW (1) | TW202045505A (enExample) |
| WO (1) | WO2020173739A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022070288A1 (ja) * | 2020-09-30 | 2022-04-07 | 旭化成ファーマ株式会社 | 含窒素二環化合物 |
| WO2025143152A1 (ja) * | 2023-12-27 | 2025-07-03 | 全薬工業株式会社 | チアゾリル－ピラゾロ［１，５－ａ］ピリジン化合物、およびそのＭＹＬＫ４阻害剤としての使用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4310109B2 (ja) * | 2001-04-26 | 2009-08-05 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | ピラゾリル基を置換基として有する含窒素縮合環化合物およびその医薬組成物 |
| EP2320907A4 (en) * | 2008-08-05 | 2012-09-05 | Merck Sharp & Dohme | THERAPEUTIC COMPOUNDS |
| US9139589B2 (en) * | 2009-01-30 | 2015-09-22 | Millennium Pharmaceuticals, Inc. | Heteroaryls and uses thereof |
| WO2014066795A1 (en) * | 2012-10-25 | 2014-05-01 | Bioenergenix | Heterocyclic compounds for the inhibition of pask |
| CN107257796A (zh) * | 2014-12-02 | 2017-10-17 | 拜耳医药股份有限公司 | 取代的吡唑并[1,5‑a]吡啶和咪唑并[1,2‑a]吡嗪及其用途 |
| WO2018200855A1 (en) * | 2017-04-27 | 2018-11-01 | The Brigham And Women's Hospital, Inc. | Novel alk2 inhibitors and methods for inhibiting bmp signaling |
-
2019
- 2019-02-25 GB GBGB1902490.0A patent/GB201902490D0/en not_active Ceased
-
2020
- 2020-02-17 WO PCT/EP2020/054122 patent/WO2020173739A1/en not_active Ceased
- 2020-02-17 SG SG11202109157TA patent/SG11202109157TA/en unknown
- 2020-02-17 JP JP2021555034A patent/JP2022525121A/ja active Pending
- 2020-02-17 PH PH1/2021/552032A patent/PH12021552032A1/en unknown
- 2020-02-17 CN CN202080016700.3A patent/CN113474344A/zh active Pending
- 2020-02-17 EP EP20706194.6A patent/EP3931191B1/en active Active
- 2020-02-17 MX MX2021010093A patent/MX2021010093A/es unknown
- 2020-02-17 US US17/433,503 patent/US20220144823A1/en not_active Abandoned
- 2020-02-17 CA CA3130154A patent/CA3130154A1/en active Pending
- 2020-02-17 ES ES20706194T patent/ES2963409T3/es active Active
- 2020-02-17 KR KR1020217030814A patent/KR20210134001A/ko not_active Ceased
- 2020-02-17 AU AU2020229041A patent/AU2020229041A1/en not_active Abandoned
- 2020-02-17 MA MA055074A patent/MA55074A/fr unknown
- 2020-02-17 BR BR112021016642A patent/BR112021016642A2/pt not_active IP Right Cessation
- 2020-02-21 AR ARP200100485A patent/AR124749A1/es not_active Application Discontinuation
- 2020-02-24 TW TW109105861A patent/TW202045505A/zh unknown
-
2021
- 2021-08-10 CO CONC2021/0010485A patent/CO2021010485A2/es unknown
- 2021-08-22 IL IL285751A patent/IL285751A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2353616C2 (ru) | Производные 2-пиридона в качестве ингибиторов эластазы нейтрофилов и их применение | |
| KR102153772B1 (ko) | 아릴 에테르 및 이의 용도 | |
| AU658441B2 (en) | Substituted beta-lactam compounds useful as hypocholesterolemic agents and processes for the preparation thereof | |
| JP5765739B2 (ja) | ロスバスタチンラクトールの薬物としての使用 | |
| IL272115B (en) | An aryl-phosphorus-oxygen compound as an egfr kinase inhibitor | |
| JP2022512482A5 (enExample) | ||
| JP7209897B2 (ja) | Ｃｒｂｎタンパク質モジュレーターとしての二環式化合物 | |
| IL286839B (en) | Propyne-indole compounds | |
| JP2006515858A5 (enExample) | ||
| JP2011037841A5 (enExample) | ||
| JP2022526553A5 (enExample) | ||
| CN106831570B (zh) | 喹啉类化合物及其制备方法和作为尿酸盐转运体抑制剂类药物的用途 | |
| JP2013518881A5 (enExample) | ||
| JP2004506718A5 (enExample) | ||
| HRP20150273T1 (hr) | Spojevi bis(floroalkil)-1,4-benzodiazepinona | |
| JP2009537469A5 (enExample) | ||
| JP2005511547A5 (enExample) | ||
| HUT66159A (en) | Pyridopyrimidine derivatives, pharmaceutical compositions containing them and process for their production | |
| JP7665774B2 (ja) | 二環式フェノール系化合物及びその使用 | |
| JP2024536863A5 (enExample) | ||
| JP2024540164A5 (enExample) | ||
| JP2006523698A5 (enExample) | ||
| WO2001062708A1 (fr) | Derives d'acide benzoique, procede de production desdits derives, et medicament contenant ces derives comme principe actif | |
| RU2006111458A (ru) | Фармацевтические композиции, содержащие малонамидные производные для уменьшения продукции кожного сала | |
| JP2006523626A5 (enExample) |